Paper39596604
Segregation of the COL6A2 Variant (c.1817-3C>G) in a Consanguineous Saudi Family with Bethlem Myopathy.
Aldharee H and 1 other. Genes (Basel), 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Segregation of the COL6A2 Variant (c.1817-3C>G) in a Consanguineous Saudi Family with Bethlem Myopathy. Papers, record 39596604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Segregation of the COL6A2 Variant (c.1817-3C>G) in a Consanguineous Saudi Family with Bethlem Myopathy.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen Type VI | Major topic |
| Pedigree | Major topic |
| Contracture | Major topic |
| Muscular Dystrophies | Major topic |
| Humans | |
| Male | |
| Saudi Arabia | |
| Child | |
| Female | |
| Consanguinity | |
| Mutation | |
| Exome Sequencing |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20033-mduc-2023-10-1-w | The researchers would like to thank the Deanship of Graduate Studies and Scientific Research at Qassim University for financial support 180 (20033-mduc-2023-10-1-w). | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30706156 | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | J Neurol | 2019 | https://conductscience.org/library/papers/30706156 | PubMed |
| 2 | 36408920 | UniProt: the Universal Protein Knowledgebase in 2023. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36408920 | PubMed |
| 3 | 34595143 | Case Report: The Genetic Diagnosis of Duchenne Muscular Dystrophy in the Middle East. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34595143 | PubMed |
| 4 | 34728949 | Genotype-Phenotype Correlation of the Childhood-Onset Bethlem Myopathy in the Mediterranean Region of Turkey. | Ann Indian Acad Neurol | 2021 | https://conductscience.org/library/papers/34728949 | PubMed |
| 5 | 24339618 | Bethlem myopathy: An autosomal dominant myopathy with flexion contractures, keloids, and follicular hyperkeratosis. | Ann Indian Acad Neurol | 2013 | https://conductscience.org/library/papers/24339618 | PubMed |
| 6 | 25741868 | Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. | Genet Med | 2015 | https://conductscience.org/library/papers/25741868 | PubMed |
| 7 | 32270339 | Duchenne Muscular Dystrophy: the Heart of the Matter. | Curr Heart Fail Rep | 2020 | https://conductscience.org/library/papers/32270339 | PubMed |
| 8 | 36808077 | Aids to the examination of the peripheral nervous system: 6th edition. | Pract Neurol | 2023 | https://conductscience.org/library/papers/36808077 | PubMed |
| 9 | 20106987 | Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20106987 | PubMed |
| 10 | 23170014 | Spontaneous keloid formation in patients with Bethlem myopathy. | Neurology | 2012 | https://conductscience.org/library/papers/23170014 | PubMed |
| 11 | 23138309 | Interpreting noncoding genetic variation in complex traits and human disease. | Nat Biotechnol | 2012 | https://conductscience.org/library/papers/23138309 | PubMed |
| 12 | 29894794 | Two novel COL6A3 mutations disrupt extracellular matrix formation and lead to myopathy from Ullrich congenital muscular dystrophy and Bethlem myopathy spectrum. | Gene | 2018 | https://conductscience.org/library/papers/29894794 | PubMed |
| 13 | 30132372 | Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There? | Hum Gene Ther | 2018 | https://conductscience.org/library/papers/30132372 | PubMed |
| 14 | 15689448 | Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. | J Med Genet | 2005 | https://conductscience.org/library/papers/15689448 | PubMed |
| 15 | 19767415 | Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. | Brain | 2009 | https://conductscience.org/library/papers/19767415 | PubMed |
| 16 | 15285897 | Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. | J Comput Biol | 2004 | https://conductscience.org/library/papers/15285897 | PubMed |
| 17 | 23074070 | Discovery of rare homozygous mutations from studies of consanguineous pedigrees. | Curr Protoc Hum Genet | 2012 | https://conductscience.org/library/papers/23074070 | PubMed |
| 18 | 25416802 | In silico prediction of splice-altering single nucleotide variants in the human genome. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/25416802 | PubMed |
| 19 | 19997069 | Sequencing technologies - the next generation. | Nat Rev Genet | 2010 | https://conductscience.org/library/papers/19997069 | PubMed |
| 20 | 34421296 | Update on Biomarkers in Spinal Muscular Atrophy. | Biomark Insights | 2021 | https://conductscience.org/library/papers/34421296 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41439068 | Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy. | Cureus | 2025 | https://conductscience.org/library/papers/41439068 | PubMed |
| 41154655 | Landscape Analysis of COL6A1, COL6A2, and COL6A3 Pathogenic Variants in a Large Italian Cohort Presenting with Collagen VI-Related Myopathies: A Nationwide Report. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154655 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CMPK1 | 51727 | PubTator's text mining | https://conductscience.org/library/genes/51727 | NCBI Gene |
| COL6A1 | 1291 | PubTator's text mining | https://conductscience.org/library/genes/1291 | NCBI Gene |
| COL6A2 | 1292 | PubTator's text mining | https://conductscience.org/library/genes/1292 | NCBI Gene |
| COL6A3 | 1293 | PubTator's text mining | https://conductscience.org/library/genes/1293 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596604
GET https://conductscience.org/api/papers/v1/39596604/references?page=2